Rong (Fiona) Huang
Lawyers
Filters
AN2 Therapeutics $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Mirion Technologies $85.6 million secondary offering
The offering consists of 9,786,153 shares of Class A common stock
Mirion Technologies $150 million registered direct offering
We advised Mirion on the offering
RxSight $50 million follow-on offering
The stock is listed on the Nasdaq Global Market
EDAP TMS $23 million follow-on offering
The ADSs are listed on the Nasdaq Global Market
Bloom Energy $388.7 million follow-on offering
The shares are listed on the NYSE
Gilead Sciences $405 million acquisition of MiroBio
We are advising Gilead Sciences on the transaction
Natus Medical $1.2 billion acquisition by ArchiMed
We are advising Natus Medical on the transaction
Weyerhaeuser $900 million notes offering and concurrent cash tender offer
The tender offer was funded with the proceeds of the investment-grade notes offering
Intuit $1 billion common stock offering
The shares are listed on Nasdaq